Stryker Corporation (SYK) is Reiterated by RBC Capital Mkts to Outperform, Raises Price Target to $ 120

Stryker Corporation (SYK) was Reiterated by RBC Capital Mkts to “Outperform” according to the research note released today. The brokerage firm has raised the Price Target to $ 120 from a previous price target of $108 . RBC Capital Mkts advised their investors in a research report released on Apr 26, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.Stryker Corporation was Initiated by Nomura to “Neutral” on Mar 17, 2016.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Stryker Corporation opened for trading at $109.44 and hit $110.06 on the upside on Friday, eventually ending the session at $109.4, with a gain of 0.08% or 0.09 points. The heightened volatility saw the trading volume jump to 18,37,756 shares. Company has a market cap of $40,804 M.

In a different news, on Apr 25, 2016, William E Jr Berry (VP, Corporate Controller) sold 3,339 shares at $109.23 per share price. According to the SEC, on Apr 25, 2016, Ronda E Stryker (director) sold 12,000 shares at $108.69 per share price. On Apr 5, 2016, Katherine Ann Owen (V.P., Strategy & Investor Rel.) sold 10,914 shares at $109.29 per share price, according to the Form-4 filing with the securities and exchange commission.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Stryker Corporation

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.